Applied Finance Capital Management’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,170
Closed -$368K 239
2026
Q1
$368K Sell
5,170
-231
-4% -$18.2K 0.03% 170
2025
Q4
$443K Sell
5,401
-3,908
-42% -$304K 0.03% 158
2025
Q3
$699K Sell
9,309
-2,190
-19% -$163K 0.05% 144
2025
Q2
$852K Buy
11,499
+2,183
+23% +$152K 0.06% 142
2025
Q1
$752K Buy
+9,316
New +$801K 0.06% 156
2024
Q4
Sell
-8,237
Closed -$773K 314
2024
Q3
$773K Buy
8,237
+341
+4% +$28.6K 0.03% 150
2024
Q2
$615K Buy
+7,896
New +$644K 0.03% 163

Other funds holding GEHC

Applied Finance Capital Management's GEHC Position: Q2 2026 in Review

Applied Finance Capital Management sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 5,170 shares — an estimated $368K sold.

Applied Finance Capital Management first reported a position in GEHC in Q2 2024 and held it in 7 quarters. The position peaked at $852K in Q2 2025. 1,224 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Applied Finance Capital Management reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Applied Finance Capital Management sold 5,170 GE HealthCare shares in Q2 2026, an estimated $368K.
  • Applied Finance Capital Management first reported a position in GE HealthCare in Q2 2024 and held it in 7 quarters.
  • Applied Finance Capital Management's GE HealthCare position peaked at $852K in Q2 2025.
  • 1,224 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Applied Finance Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.